Seeking Alpha

BioMarin Pharmaceutical (BMRN): Q2 EPS of -$0.27 may not be comparable to consensus of -$0.19....

BioMarin Pharmaceutical (BMRN): Q2 EPS of -$0.27 may not be comparable to consensus of -$0.19. Revenue of $124M (+12.1% Y/Y) beats by $2.5M. Shares +1.1% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|